Skip to main content

Table 1 Baseline characteristics and treatment outcome of TNBC patients treated with neoadjuvant chemotherapy (N = 61)

From: Topographic expression of the Hippo transducers TAZ and YAP in triple-negative breast cancer treated with neoadjuvant chemotherapy

Characteristics N (%)
Age at diagnosis
Mean ± SD 49.8 ± 11.4
Median (min-max)[IQrange] 48.4 (25.6–76.6) [44.3–58.3]
Stage
 II 21 (34.4)
 III 40 (65.6)
Ki-67
 Mean ± SD 58.2 ± 24.7
 Median (min-max)[IQrange] 60 (10–90) [40–80]
Grade
 1–2 22 (36.1)
 3 39 (63.9)
Chemotherapy
 Sequential 52 (85.2)
 Concomitant 9 (14.8)
Pathological complete response
 Yes 18 (29.5)
 No 43 (70.5)